Guoliang N. Shao
No. 1 Banshan East Road
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Population pharmacokinetics and dose evaluation for second-line TB drugs in patients with diabetes.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: March 29, 2025
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: October 12, 2024
A Comparative Study of DC Beads, Callispheres and Multimodal Imaging Nano-Assembled Microspheres Loaded with Irinotecan in Vitro.
Journal: Technology in cancer research & treatment
Published: August 16, 2024
A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy.
Journal: Frontiers in immunology
Published: July 17, 2024
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.
Journal: JHEP reports : innovation in hepatology
Published: December 15, 2023
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 02, 2023
Radioactive 125I Seed Inhibits Cell Migration and Invasion and Promotes Apoptosis by Inactivating the VEGFR2 Signaling Pathway in Cholangiocarcinoma.
Journal: Dose-response : a publication of International Hormesis Society
Published: July 10, 2023
Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE.
Journal: Medicine
Published: June 16, 2023
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial.
Journal: Frontiers in immunology
Published: June 12, 2023
Using host-guest interactions at the interface of quantum dots to load drug molecules for biocompatible, safe, and effective chemo-photodynamic therapy against cancer.
Journal: Journal of materials chemistry. B
Published: May 10, 2023
Last Updated: 09/26/2026